GPO ramps up domestic antiviral production following shortage concerns
The Government Pharmaceutical Organization is expected to produce Favipiravir antiviral medication for COVID-19 treatment of more than 40 million tablets per month from October onwards, following concerns raised by hospitals on potential shortages. The Government Pharmaceutical Organization (GPO) has revealed its expected production yield of locally produced Favipiravir is 2.5…
GPO secures deals to sell Moderna vaccinations to private hospitals
Faripiravir produced by the Government Pharmaceutical Organization (GPO) has received registration with the Food and Drug Administration (FDA) and should be able to begin distribution to those in need from August, with the organization also closing deals to sell Moderna brand COVID-19 vacine doses to a private hospital ahead of…
GPO denies overcharging for Moderna jabs
The Government Pharmaceutical Organization (GPO), insisted today that the price per-dose of the Moderna vaccine it plans to sell to private hospitals, reflects actual costs, dismissing allegations of overcharging. The Government Pharmaceutical Organization (GPO) has also released a statement in which it responds to allegations the organization is overcharging private…
Pharmaceutical Organization will import 11 million Sinovac doses from June
The Government Pharmaceutical Organization (GPO) will import 11 million Sinovac doses from June to August, to support the government’s plan to procure at least 100 million vaccine doses for the country. Public Health Minister Anutin Charnvirakul said, so far, the ministry has received 6 million doses of the Sinovac vaccine,…